President, CEO of Chinook Therapeutics, Inc. (NASDAQ:KDNY), Dobmeier Eric, buys 929 shares worth $12,699
According to Chinook Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 23 07:26 PM, company President, CEO, Dobmeier Eric disclosed buying 929 shares at a cost of $13.67. At the time of this transaction (Nov 23), this trade was worth $12,699 in total. As of Nov 23, Dobmeier Eric now owns 52,837 shares in total worth about $720,168.31.
For the last few recent trades made by Chinook Therapeutics, Inc. (NASDAQ:KDNY) President, CEO, Dobmeier Eric, we have the following information:
- SEC Form 4 filing: Nov 19: Bought 500 shares at the rate of $13.50 per share. Total worth of this trade was $6,750. Total number of shares owned as of Nov 19 were 51,337
- SEC Form 4 filing: Nov 20: Bought 571 shares at the rate of $13.69 per share. Total worth of this trade was $7,817. Total number of shares owned as of Nov 20 were 51,908
- SEC Form 4 filing: Nov 10: Bought 2,000 shares at the rate of $13.86 per share. Total worth of this trade was $27,720. Total number of shares owned as of Nov 10 were 48,337
Posted by
George Daniels
on Tuesday November 24 2020, 12:16 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
